Literature DB >> 32494825

Acquired Haemophilia A in DPP4 Inhibitor-induced Bullous Pemphigoid as Immune Reconstitution Syndrome.

Seiko Sugiyama1, Ryota Tanaka, Hiroaki Hayashi, Kentaro Izumi, Wataru Nishie, Yumi Aoyama.   

Abstract

Entities:  

Keywords:  bullous pemphigoid; dipeptidyl peptidase 4 inhibitors; acquired hemophilia A

Mesh：

Substances：

Year:  2020        PMID： 32494825      PMCID： PMC9175053          DOI： 10.2340/00015555-3539

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  14 in total

1.  Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).

Authors:  Bertram Bengsch; Bianca Seigel; Tobias Flecken; Julia Wolanski; Hubert E Blum; Robert Thimme
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

Review 2.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

Review 3.  A case of acquired haemophilia A in a patient with bullous pemphigoid and review of the Japanese literature.

Authors:  Chika Chijiwa; Masahiro Kamata; Atsuko Fukuyasu; Yuki Shono; Shintaro Takeoka; Mihoko Tateishi; Saki Fukaya; Kotaro Hayashi; Takamitsu Tanaka; Takeko Ishikawa; Takamitsu Ohnishi; Koji Saito; Norito Ishii; Takashi Hashimoto; Yayoi Tada
Journal:  Eur J Dermatol       Date:  2018-06-01       Impact factor: 3.328

4.  Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf study.

Authors:  R Gheisari; B Bomke; T Hoffmann; R E Scharf
Journal:  Hamostaseologie       Date:  2010-08       Impact factor: 1.778

Review 5.  Acquired hemophilia A: Updated review of evidence and treatment guidance.

Authors:  Rebecca Kruse-Jarres; Christine L Kempton; Francesco Baudo; Peter W Collins; Paul Knoebl; Cindy A Leissinger; Andreas Tiede; Craig M Kessler
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

Review 6.  Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy.

Authors:  Tetsuo Shiohara; Maiko Kurata; Yoshiko Mizukawa; Yoko Kano
Journal:  Allergol Int       Date:  2010-10-25       Impact factor: 5.836

7.  Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  Peter Collins; Francesco Baudo; Paul Knoebl; Hervé Lévesque; László Nemes; Fabio Pellegrini; Pascual Marco; Lilian Tengborn; Angela Huth-Kühne
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

Review 8.  Bullous pemphigoid complicated by cytomegalovirus disease as a manifestation of immune reconstitution inflammatory syndrome: retrospective analyses of our institutional cases and literature review.

Authors:  Yoko M Narita; Chiho Horie; Kazuhisa Hirahara; Yoko Kano; Tetsuo Shiohara; Yoshiko Mizukawa
Journal:  Int J Dermatol       Date:  2017-12-02       Impact factor: 2.736

9.  Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes.

Authors:  Yoshimasa Aso; Maiko Fukushima; Masaaki Sagara; Teruo Jojima; Toshie Iijima; Kunihiro Suzuki; Atsushi Momobayashi; Kikuo Kasai; Toshihiko Inukai
Journal:  Diabetes Res Clin Pract       Date:  2015-10-20       Impact factor: 5.602

10.  Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature.

Authors:  Quentin Binet; Catherine Lambert; Laurine Sacré; Stéphane Eeckhoudt; Cedric Hermans
Journal:  Case Rep Hematol       Date:  2017-03-28
View more
  2 in total

Review 1.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

Review 2.  Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions.

Authors:  Yumi Aoyama; Seiko Sugiyama; Takenobu Yamamoto
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.